BioCentury
ARTICLE | Company News

IntelliCell, Global Alliance for Innovation in Neuroscience deal

March 24, 2014 7:00 AM UTC

The companies partnered to conduct studies of IntelliCell's stromal vascular fraction cells to treat neurological disorders, including autism, Alzheimer's dementia and blast-induced traumatic brain in...